The effect of laughter therapy on radiation dermatitis in patients with breast cancer: A single-blind prospective pilot study

OncoTargets and Therapy

Volumn 7, Issue , 2014, Pages 2053-2059

  Kong, Moonkyoo ^a   Shin, Sung Hee ^b   Lee, Eunmi ^c   Yun, Eun Kyoung ^b  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

^c Kyung Hee University College of Medicine   (South Korea)

Author keywords

Breast cancer; Laughter therapy; Radiation dermatitis; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; BODY MASS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; LYMPH NODE IRRADIATION; PILOT STUDY; RADIATION DERMATITIS; RADIATION DOSE; SCORING SYSTEM; SINGLE BLIND PROCEDURE; VISUAL ANALOG SCALE;

EID: 84908664203     PISSN: 11786930     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S72973     Document Type: Article

References (32)

1. Ha B, Suh HS, Lee J, Lee KJ, Lee R, Moon BI. Long-term results of forward intensity-modulated radiation therapy for patients with early-stage breast cancer. Radiat Oncol J. 2013;31(4):191-198.
2. Harper JL, Franklin LE, Jenrette JM, Aguero EG. Skin toxicity during breast irradiation: pathophysiology and management. South Med J. 2004;97(10):989-993.
3. Graham PH, Plant N, Graham JL, et al. A paired, double-blind, randomized comparison of a moisturizing durable barrier cream to 10% glycerine cream in the prophylactic management of postmastectomy irradiation skin care: trans Tasman Radiation Oncology Group (TROG) 04.01. Int J Radiat Oncol Biol Phys. 2013;86(1):45-50.
4. Kong M, Hong SE. Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study. Asian Pac J Cancer Prev. 2013;14(8):4859-4864.
5. Pinnix C, Perkins GH, Strom EA, et al. Topical hyaluronic acid vs standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial. Int J Radiat Oncol Biol Phys. 2012;83(4):1089-1094.
6. Hemati S, Asnaashari O, Sarvizadeh M, et al. Topical silver sulfadiaz-ine for the prevention of acute dermatitis during irradiation for breast cancer. Support Care Cancer. 2012;20(8):1613-1618.
7. Kirova YM, Fromantin I, De Rycke Y, et al. Can we decrease the skin reaction in breast cancer patients using hyaluronic acid during radiation therapy? Results of phase III randomised trial. Radiother Oncol. 2011;100(2):205-209.
8. Merchant TE, Bosley C, Smith J, et al. A phase III trial comparing an anionic phospholipid-based cream and aloe vera-based gel in the prevention of radiation dermatitis in pediatric patients. Radiat Oncol. 2007;2:45.
9. Pommier P, Gomez F, Sunyach M P, D’Hombres A, Carrie C, Montbarbon X. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol. 2004;22(8):1447-1453.
10. Cousins N. Anatomy of an illness (as perceived by the patient). N Engl J Med. 1976;295(26):1458-1463.
11. Bellert JL. Humor. A therapeutic approach in oncology nursing. Cancer Nurs. 1989;12(2):65-70.
12. Erdman L. Laughter therapy for patients with cancer. Oncol Nurs Forum. 1991;18(8):1359-1363.
13. Penson RT, Partridge RA, Rudd P, et al. Laughter: the best medicine? Oncologist. 2005;10(8):651-660.
14. Saper B. The therapeutic use of humor for psychiatric disturbances of adolescents and adults. Psychiatr Q. 1990;61(4):261-272.
15. Gelkopf M, Kreitler S, Sigal M. Laughter in a psychiatric ward. Somatic, emotional, social, and clinical infuences on schizophrenic patients. J Nerv Ment Dis. 1993;181(5):283-289.
16. van Alphen PJ. Humor as diagnostic and therapeutic tool in psychiatry. Laughter is healthy. TVZ. 1997;107(22):674-677. Dutch.
17. Basmajian J V. The elixir of laughter in rehabilitation. Arch Phys Med Rehabil. 1998;79(12):1597.
18. Bennett M P, Zeller JM, Rosenberg L, McCann J. The effect of mirthful laughter on stress and natural killer cell activity. Altern Ther Health Med. 2003;9(2):38-45.
19. Bukutu C, Le C, Vohra S. Asthma: a review of complementary and alternative therapies. Pediatr Rev. 2008;29(8):e44-e49.
20. Borod M. SMILES - toward a better laughter life: a model for introducing humor in the palliative care setting. J Cancer Educ. 2006;21(1):30-34.
21. Bennett M, Lengacher C. Use of complementary therapies in a rural cancer population. Oncol Nurs Forum. 1999;26(8):1287-1294.
22. Lengacher C., Bennett M P, Kip KE, et al. Frequency of use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum. 2002;29(10):1445-1452.
23. Kimata H. Effect of humor on allergen-induced wheal reactions. JAMA. 2001;285(6):738.
24. Kimata H. Laughter counteracts enhancement of plasma neurotrophin levels and allergic skin wheal responses by mobile phone-mediated stress. Behav Med. 2004;29(4):149-152.
25. Kimata H. Laughter elevates the levels of breast-milk melatonin. J Psychosom Res. 2007;62(6):699-702.
26. Mora-Ripoll R. The therapeutic value of laughter in medicine. Altern Ther Health Med. 2010;16(6):56-64.
27. Yoshino S, Fujimori J, Kohda M. Effects of mirthful laughter on neu-roendocrine and immune systems in patients with rheumatoid arthritis. J Rheumatol. 1996;23(4):793-794.
28. Weisenberg M, Raz T, Hener T. The influence of film-induced mood on pain perception. Pain. 1998;76(3):365-375.
29. Cogan R, Cogan D, Waltz W, McCue M. Effects of laughter and relaxation on discomfort thresholds. J Behav Med. 1987;10(2):139-144.
30. Van Zandt S, LaFont C. Can a laugh a day keep the doctor away? J Pract Nurs. 1985;35(3):32-35.
31. Fernando IN, Ford HT, Powles TJ, et al. Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: a prospective study of treatment practice at the Royal Marsden Hospital. Clin Oncol (R Coll Radiol). 1996;8(4):226-233.
32. Fisher J, Scott C, Stevens R, et al. Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys. 2000;48(5):1307-1310.